SurModics Announces 2017 Annual Shareholders Meeting Post author:Sam Post published:February 8, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Genentech's Top Cancer Prospect Flunks Phase III Test May 9, 2017 Why Secretive $5 Billion Biotech Moderna May Not be Able to Commercialize Products Into Clinical Trials February 13, 2017 <b>Chris Varma</b>, Co-Founder And Former President And CEO Of Blueprint Medicines, Joins MPM As Entrepreneur-In-Residence February 6, 2017
Why Secretive $5 Billion Biotech Moderna May Not be Able to Commercialize Products Into Clinical Trials February 13, 2017
<b>Chris Varma</b>, Co-Founder And Former President And CEO Of Blueprint Medicines, Joins MPM As Entrepreneur-In-Residence February 6, 2017